Medifast
NYSE:MED
$ 9,59
$-0,51 (-5,05%)
9,59 $
$-0,51 (-5,05%)
End-of-day quote: 03/24/2026

Medifast Stock Value

The analyst rating for Medifast is currently Hold.
Hold
Hold

Medifast Company Info

EPS Growth 5Y
-32,95%
Market Cap
$0,10 B
Long-Term Debt
$0,00 B
Short Interest
7,48%
Quarterly earnings
04/28/2026 (E)
Dividend
$0,00
Dividend Yield
0,00%
Founded
1980
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$12,00
25.13%
25.13
Last Update: 03/22/2026
Analysts: 1

Highest Price Target $12,00

Average Price Target $12,00

Lowest Price Target $12,00

In the last five quarters, Medifast’s Price Target has fallen from $22,64 to $15,75 - a -30,43% decrease. One analysts predict that Medifast’s share price will increase in the coming year, reaching $12,00. This would represent an increase of 25,13%.

Top growth stocks in the consumer discretionary sector (5Y.)

What does Medifast do?

Medifast, Inc. (Medifast) operates as a health and wellness company in the United States (U.S.). The company’s habit-based and coach-guided lifestyle solution is OPTAVIA. The company has initiated its business transformation by expanding into the medically supported weight loss and sports nutrition markets, reflecting its commitment to providing comprehensive health and wellness solutions to customers as both their needs and the industry evolve. Medifast has created a well-capitalized business...
×